Rare Cancer Treatments, Cleared by FDA but Not Subject to Scrutiny

Rare Cancer Treatments, Cleared by FDA but Not Subject to Scrutiny

The reason: The group of woman for whom the F.D.A. approved the treatment — those with advanced cervical cancer who are too ill for chemotherapy — is so small. “I see, like, one patient like this a year,” said Dr. Junzo P. Chino, a cancer expert at

4
Like
Save

Comments

Write a comment

*